Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
2011

Understanding Allosteric Interactions in Abl Kinase for Overcoming Drug Resistance

publication Evidence: moderate

Author Information

Author(s): Iacob Roxana E., Zhang Jianming, Gray Nathanael S., Engen John R.

Primary Institution: Northeastern University, Boston, Massachusetts, USA

Hypothesis

How does drug binding at a distance from the kinase active site lead to inhibition and how can inhibitors combine their effects?

Conclusion

The study provides evidence that allosteric interactions play a significant role in Abl kinase downregulation, suggesting that targeting sites outside the ATP binding site can help overcome drug resistance.

Supporting Evidence

  • Dasatinib binding to wild type Abl influenced Abl conformation.
  • GNF-5 caused conformational changes in both wild type and T315I mutants.
  • Simultaneous binding of dasatinib and GNF-5 to T315I resulted in similar effects as dasatinib binding to wild type Abl.
  • Targeting the myristate binding site can suppress drug-resistant mutations.

Takeaway

This study shows that certain drugs can work together to stop cancer cells from growing, even when they have mutations that make them resistant to treatment.

Methodology

Hydrogen exchange mass spectrometry was used to study conformational effects of drug binding on Abl kinase.

Limitations

The study primarily focuses on specific mutations and may not generalize to all forms of drug resistance.

Digital Object Identifier (DOI)

10.1371/journal.pone.0015929

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication